Ethics assessment in research proposals adopting CRISPR technology.


Journal

Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305

Informations de publication

Date de publication:
15 Jun 2019
Historique:
received: 12 03 2019
accepted: 23 04 2019
entrez: 22 6 2019
pubmed: 22 6 2019
medline: 31 8 2019
Statut: ppublish

Résumé

The rapid and exponential growth of genome editing has posed many challenges for bioethics. This article briefly explains the nature of the technique and the particularly rapid development of Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) technology. The international and, specifically, European-level systems for assessing the ethical issues consequent on these developments are outlined and discussed. The challenges posed by cases in China are summarized to raise concerns about how a more shared, universally consistent appraisal of bioethical issues can be promoted.

Identifiants

pubmed: 31223254
doi: 10.11613/BM.2019.020202
pii: bm-29-2-020202
pmc: PMC6559619
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

020202

Déclaration de conflit d'intérêts

Potential conflict of interest: None declared.

Références

Science. 2011 Jul 15;333(6040):307
pubmed: 21700836
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
Protein Cell. 2015 May;6(5):363-372
pubmed: 25894090
Trends Microbiol. 2016 Oct;24(10):811-820
pubmed: 27401123
Nature. 2017 Jan 4;541(7635):30
pubmed: 28054606
Development. 2017 Jul 15;144(14):2541-2543
pubmed: 28720650
Transgenic Res. 2017 Oct;26(5):709-713
pubmed: 28730514
Nature. 2017 Aug 24;548(7668):413-419
pubmed: 28783728
Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):418-423
pubmed: 28885275
Linacre Q. 2017 Aug;84(3):226-231
pubmed: 28912615
Prog Mol Biol Transl Sci. 2017;152:95-114
pubmed: 29150007
Drug Deliv. 2018 Nov;25(1):1234-1257
pubmed: 29801422
Nat Biotechnol. 2018 Jun 6;36(6):485
pubmed: 29874214
Trends Biotechnol. 2018 Aug;36(8):741-743
pubmed: 29891181
Stem Cells Int. 2018 Aug 26;2018:1429351
pubmed: 30254679
Nature. 2018 Dec;564(7734):13-14
pubmed: 30514937
Lancet. 2018 Dec 8;392(10163):2413
pubmed: 30527398
Nature. 2019 Feb;566(7745):440-442
pubmed: 30809070
Haematologica. 2019 May;104(5):881-893
pubmed: 30923099
Semin Cell Dev Biol. 2019 Apr 6;:null
pubmed: 30951893
Plasmid. 2019 May;103:25-35
pubmed: 30954454
CRISPR J. 2018 Apr;1:128-129
pubmed: 31021207
Hum Reprod. 1997 Sep;12(9):2076-80
pubmed: 9363733
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14628-33
pubmed: 9843940

Auteurs

Francois Hirsch (F)

Ethics Committee of the French National Institute of Health and Medical Research (INSERM), Paris, France.

Ron Iphofen (R)

Independent Research Consultant, La Rochelle, France.

Zvonimir Koporc (Z)

Catholic University of Croatia, Zagreb, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH